Literature DB >> 10649532

Neuropsychiatric correlates of memory-metamemory dissociations in HIV-infection.

S B Rourke1, M H Halman, C Bassel.   

Abstract

Ninety-one adults with HIV-infection who varied in the concordance between their subjective memory complaints (or metamemory) on the Patient's Assessment of Own Functioning (Chelune, Heaton, & Lehman, 1986) and their memory performance on the California Verbal Learning Test (CVLT), were compared on the Beck Depression Inventory (BDI), and on neuropsychological (NP) tests of attention, language, psychomotor speed, and conceptual problem-solving. Subjects with low memory complaints and normal CVLT performance (n = 29) had low BDI scores and were normal in all other NP abilities. Subjects with high memory complaints and impaired CVLT performance (n = 20) had elevations on the BDI as well as NP impairments in psychomotor speed and category fluency. Subjects with low memory complaints but impaired CVLT performance (n = 16) had low BDI scores and were selectively impaired in conceptual problem-solving. Subjects with high memory complaints but normal CVLT performance (n = 26) had high BDI scores and normal NP functioning in all other abilities. These results suggest that there are at least two key determinants to metamemory inaccuracy in HIV-infection, namely, frontal executive impairments and mood disturbance.

Entities:  

Mesh:

Year:  1999        PMID: 10649532     DOI: 10.1076/jcen.21.6.757.852

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  16 in total

1.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

Review 2.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

3.  Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV.

Authors:  Steven Paul Woods; Catherine L Carey; Lisa M Moran; Matthew S Dawson; Scott L Letendre; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2007-02-06       Impact factor: 2.813

4.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

5.  Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Authors:  Stephanie Chiao; Howard J Rosen; Krista Nicolas; Lauren A Wendelken; Oscar Alcantar; Katherine P Rankin; Bruce Miller; Victor Valcour
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-20       Impact factor: 2.205

6.  Self-predictions of prospective memory in HIV-associated neurocognitive disorders: evidence of a metamemory deficit.

Authors:  Kaitlin Blackstone Casaletto; Katie L Doyle; Erica Weber; Steven Paul Woods
Journal:  Arch Clin Neuropsychol       Date:  2014-12       Impact factor: 2.813

7.  Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.

Authors:  Mandy J Bell; Lauren Terhorst; Catherine M Bender
Journal:  J Nurs Meas       Date:  2013

8.  Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.

Authors:  K Blackstone; D J Moore; R K Heaton; D R Franklin; S P Woods; D B Clifford; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; M Rivera-Mindt; R Deutsch; R J Ellis; J Hampton Atkinson; I Grant
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

9.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.

Authors:  K L Pomykala; P A Ganz; J E Bower; L Kwan; S A Castellon; S Mallam; I Cheng; R Ahn; E C Breen; M R Irwin; D H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

10.  Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient's Assessment of Own Functioning Inventory (PAOFI).

Authors:  Randall Richardson-Vejlgaard; Sharron Dawes; Robert K Heaton; Morris D Bell
Journal:  Psychiatry Res       Date:  2009-07-19       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.